The largest database of trusted experimental protocols

Rimonabant hydrochloride

Manufactured by Merck Group
Sourced in United States

Rimonabant hydrochloride is a synthetic cannabinoid receptor antagonist compound. It is used as a research chemical in laboratory settings to study the endocannabinoid system and related physiological processes.

Automatically generated - may contain errors

3 protocols using rimonabant hydrochloride

1

Cannabinoid Receptor Modulation in Vitro

Check if the same lab product or an alternative is used in the 5 most similar protocols
Reagents for in vitro experiments included SR141716A (Rimonabant hydrochloride, 5 μM, Sigma), WIN55,212–2 (Tocris), GAT211 (5 μM, Sigma) were dissolved in 0.5% DMSO.
+ Open protocol
+ Expand
2

Cannabinoid Receptor Modulation in Cell Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Arachidonyl-2′-chloroethylamide hydrate (ACEA; CB1 agonist), Rimonabant hydrochloride (SR141716A; CB1 antagonist/inverse agonist), GW833972A (CB2 agonist), SR144528 (CB2 antagonist/inverse agonist), and dimethyl sulfoxide (DMSO) (Sigma-Aldrich, St. Louis, MO, USA) were used. These cannabinoid receptor agonists and antagonists were dissolved in DMSO at a concentration of 20 mM and stored at −20 °C until used.
Saponin (Amresco, Solon, OH, USA) was used. Carboxyfluorescein succinimidyl ester (CFSE), brefeldin A, and monensin were obtained from Sigma-Aldrich. RPMI 1640 medium and fetal bovine serum (FBS) (Gibco, Grand Island, NY, USA) were used. Ficoll-Hypaque solution (IsoPrep)(Robbins Scientific Corporation, Sunnyvale, CA, USA) was used. Finally, 7-AAD solution was purchased from BioLegend.
+ Open protocol
+ Expand
3

Quantification of CB1 Receptor Binding in BAT

Check if the same lab product or an alternative is used in the 5 most similar protocols
Biopsies of intrascapular BAT (iBAT) and subcutaneous WAT from Sprague-Dawley rats were frozen to 280°C and processed into 10-mm sections. To study tracer binding properties to the tissue, the sections were incubated in concentrations in the nanomolar range (0.05-1.5 nM) of 18 F-FMPEP-d 2 in 50 mM Tris-HCl (pH 7.6) for 90 min at room temperature. Nondisplaceable binding was assessed by adding 10 mM of the CB1 antagonist rimonabant (rimonabant hydrochloride; Sigma-Aldrich) 10 min before 18 F-FMPEP-d 2 . Tissue slices were then washed 3 times for 4 min in 50 mM ice-cold Tris to remove excess tracer and then air-dried. The sections were exposed against a phosphor-imager screen (Fuji BAS-TR2025; Fuji Photo Film Co.) for 3 h, digitalized using a BAS-5000 Fuji scanner (Fujifilm Life Science), and analyzed using the AIDA 4 (Raytest) software.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!